These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23199325)

  • 21. Antiendomysial antibody detection in fecal supernatants: in vivo proof that small bowel mucosa is the site of antiendomysial antibody production.
    Picarelli A; Sabbatella L; Di TM; Di CT; Vetrano S; Anania MC
    Am J Gastroenterol; 2002 Jan; 97(1):95-8. PubMed ID: 11808976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simultaneous detection of IgA and IgG antibodies against tissue transglutaminase: The preferred pre-biopsy test in childhood celiac disease.
    Dahlbom I; Nyberg BI; Berntson L; Hansson T
    Scand J Clin Lab Invest; 2016; 76(3):208-16. PubMed ID: 26924622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies.
    Korponay-Szabó IR; Halttunen T; Szalai Z; Laurila K; Király R; Kovács JB; Fésüs L; Mäki M
    Gut; 2004 May; 53(5):641-8. PubMed ID: 15082580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gluten-dependent small bowel mucosal transglutaminase 2-specific IgA deposits in overt and mild enteropathy coeliac disease.
    Koskinen O; Collin P; Korponay-Szabo I; Salmi T; Iltanen S; Haimila K; Partanen J; Mäki M; Kaukinen K
    J Pediatr Gastroenterol Nutr; 2008 Oct; 47(4):436-42. PubMed ID: 18852635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
    Lindfors K; Mäki M; Kaukinen K
    Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay.
    Mankaï A; Sakly W; Landolsi H; Gueddah L; Sriha B; Ayadi A; Sfar MT; Skandrani K; Harbi A; Essoussi AS; Korbi S; Fabien N; Jeddi M; Ghedira I
    Pathol Biol (Paris); 2005 May; 53(4):204-9. PubMed ID: 15850953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interpretation of serological tests in the diagnosis of celiac disease: Anti-deamidated gliadin peptide antibodies revisited.
    Zucchini L; Giusti D; Gatouillat G; Servettaz A; Tabary T; Barbe C; Pham BN
    Autoimmunity; 2016 Sep; 49(6):414-420. PubMed ID: 27452003
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AGA Clinical Practice Update on Diagnosis and Monitoring of Celiac Disease-Changing Utility of Serology and Histologic Measures: Expert Review.
    Husby S; Murray JA; Katzka DA
    Gastroenterology; 2019 Mar; 156(4):885-889. PubMed ID: 30578783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Celiac anti-type 2 transglutaminase antibodies induce differential effects in fibroblasts from celiac disease patients and from healthy subjects.
    Paolella G; Lepretti M; Barone MV; Nanayakkara M; Di Zenzo M; Sblattero D; Auricchio S; Esposito C; Caputo I
    Amino Acids; 2017 Mar; 49(3):541-550. PubMed ID: 27613408
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of anti-endomysial and anti-tissue transglutaminase autoantibodies in media following culture of oral biopsies from patients with untreated coeliac disease.
    Vetrano S; Zampaletta U; Anania MC; Di Tola M; Sabbatella L; Passarelli F; Maffia C; Sanjust MG; Lettieri F; De Pità O; Picarelli A
    Dig Liver Dis; 2007 Oct; 39(10):911-6. PubMed ID: 17719860
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Follow-up of pediatric celiac disease: value of antibodies in predicting mucosal healing, a prospective cohort study.
    Vécsei E; Steinwendner S; Kogler H; Innerhofer A; Hammer K; Haas OA; Amann G; Chott A; Vogelsang H; Schoenlechner R; Huf W; Vécsei A
    BMC Gastroenterol; 2014 Feb; 14():28. PubMed ID: 24524430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oats do not induce systemic or mucosal autoantibody response in children with coeliac disease.
    Koskinen O; Villanen M; Korponay-Szabo I; Lindfors K; Mäki M; Kaukinen K
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):559-65. PubMed ID: 19412007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific celiac disease antibodies in children on a gluten-free diet.
    Hogen Esch CE; Wolters VM; Gerritsen SA; Putter H; von Blomberg BM; van Hoogstraten IM; Houwen RH; van der Lely N; Mearin ML
    Pediatrics; 2011 Sep; 128(3):547-52. PubMed ID: 21859913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal transglutaminase 2 specific antibody deposits in non-responsive coeliac disease.
    Koskinen O; Lindfors K; Collin P; Peräaho M; Laurila K; Woolley N; Partanen J; Mäki M; Kaukinen K
    Dig Liver Dis; 2010 Oct; 42(10):692-7. PubMed ID: 20409763
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of human-tissue transglutaminase IgG and anti-gliadin IgG antibodies in the diagnosis of coeliac disease in patients with selective immunoglobulin A deficiency.
    Lenhardt A; Plebani A; Marchetti F; Gerarduzzi T; Not T; Meini A; Villanacci V; Martelossi S; Ventura A
    Dig Liver Dis; 2004 Nov; 36(11):730-4. PubMed ID: 15571003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased density of tolerogenic dendritic cells in the small bowel mucosa of celiac patients.
    Vorobjova T; Uibo O; Heilman K; Uibo R
    World J Gastroenterol; 2015 Jan; 21(2):439-52. PubMed ID: 25593459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Small-bowel mucosal transglutaminase 2-specific IgA deposits in coeliac disease without villous atrophy: a prospective and randomized clinical study.
    Kaukinen K; Peräaho M; Collin P; Partanen J; Woolley N; Kaartinen T; Nuutinen T; Halttunen T; Mäki M; Korponay-Szabo I
    Scand J Gastroenterol; 2005 May; 40(5):564-72. PubMed ID: 16036509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Missing endomysial and reticulin binding of coeliac antibodies in transglutaminase 2 knockout tissues.
    Korponay-Szabó IR; Laurila K; Szondy Z; Halttunen T; Szalai Z; Dahlbom I; Rantala I; Kovács JB; Fésüs L; Mäki M
    Gut; 2003 Feb; 52(2):199-204. PubMed ID: 12524400
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epithelial transport and deamidation of gliadin peptides: a role for coeliac disease patient immunoglobulin A.
    Rauhavirta T; Qiao SW; Jiang Z; Myrsky E; Loponen J; Korponay-Szabó IR; Salovaara H; Garcia-Horsman JA; Venäläinen J; Männistö PT; Collighan R; Mongeot A; Griffin M; Mäki M; Kaukinen K; Lindfors K
    Clin Exp Immunol; 2011 Apr; 164(1):127-36. PubMed ID: 21235541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Small bowel transglutaminase 2-specific IgA deposits in dermatitis herpetiformis.
    Salmi TT; Hervonen K; Laurila K; Collin P; Mäki M; Koskinen O; Huhtala H; Kaukinen K; Reunala T
    Acta Derm Venereol; 2014 Jul; 94(4):393-7. PubMed ID: 24352382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.